Rick Wise
Stock Analyst at Stifel
(4.44)
# 254
Out of 4,843 analysts
237
Total ratings
65.28%
Success rate
11.54%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $138 → $115 | $92.17 | +24.77% | 15 | May 6, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $280 → $224 | $172.59 | +29.79% | 8 | May 2, 2025 | |
| CNMD CONMED | Downgrades: Hold | $75 → $55 | $56.75 | -3.08% | 11 | Apr 28, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $135 → $145 | $133.58 | +8.55% | 20 | Apr 17, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $28 | $22.58 | +24.00% | 1 | Mar 31, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $40 → $32 | $20.09 | +59.32% | 6 | Mar 5, 2025 | |
| LIVN LivaNova | Maintains: Buy | $72 → $60 | $43.25 | +38.73% | 6 | Feb 26, 2025 | |
| AORT Artivion | Maintains: Buy | $33 → $30 | $29.58 | +1.42% | 6 | Feb 25, 2025 | |
| ATRC AtriCure | Maintains: Buy | $36 → $48 | $34.57 | +38.85% | 13 | Feb 13, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $115 → $120 | $105.26 | +14.00% | 17 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 → $90 | $78.22 | +15.06% | 23 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $382.64 | +14.99% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $170 → $155 | $155.21 | -0.14% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $552.34 | +10.44% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $162.50 | +16.92% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $30.50 | +24.59% | 8 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $8 | $5.76 | +38.89% | 8 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $3.40 | +370.59% | 4 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $82 | $73.09 | +12.19% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $102 | $70.54 | +44.60% | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $85 → $87 | $82.98 | +4.84% | 11 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $5.27 | +127.70% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $82.20 | -8.76% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $19.82 | +21.09% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $90 | $17.75 | +407.04% | 4 | Oct 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $12.57 | +98.89% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $52.83 | +112.00% | 5 | Oct 2, 2020 |
Zimmer Biomet Holdings
May 6, 2025
Maintains: Buy
Price Target: $138 → $115
Current: $92.17
Upside: +24.77%
Becton, Dickinson and Company
May 2, 2025
Maintains: Buy
Price Target: $280 → $224
Current: $172.59
Upside: +29.79%
CONMED
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $56.75
Upside: -3.08%
Abbott Laboratories
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $133.58
Upside: +8.55%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $22.58
Upside: +24.00%
OrthoPediatrics
Mar 5, 2025
Maintains: Buy
Price Target: $40 → $32
Current: $20.09
Upside: +59.32%
LivaNova
Feb 26, 2025
Maintains: Buy
Price Target: $72 → $60
Current: $43.25
Upside: +38.73%
Artivion
Feb 25, 2025
Maintains: Buy
Price Target: $33 → $30
Current: $29.58
Upside: +1.42%
AtriCure
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $34.57
Upside: +38.85%
Boston Scientific
Feb 10, 2025
Maintains: Buy
Price Target: $115 → $120
Current: $105.26
Upside: +14.00%
Jan 30, 2025
Upgrades: Buy
Price Target: $75 → $90
Current: $78.22
Upside: +15.06%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $382.64
Upside: +14.99%
Jan 23, 2025
Maintains: Hold
Price Target: $170 → $155
Current: $155.21
Upside: -0.14%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $552.34
Upside: +10.44%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $162.50
Upside: +16.92%
Nov 11, 2024
Maintains: Buy
Price Target: $46 → $38
Current: $30.50
Upside: +24.59%
Nov 6, 2024
Maintains: Hold
Price Target: $7 → $8
Current: $5.76
Upside: +38.89%
Oct 31, 2024
Maintains: Buy
Price Target: $17 → $16
Current: $3.40
Upside: +370.59%
Oct 8, 2024
Initiates: Buy
Price Target: $82
Current: $73.09
Upside: +12.19%
Sep 30, 2024
Maintains: Buy
Price Target: $100 → $102
Current: $70.54
Upside: +44.60%
Aug 21, 2024
Maintains: Hold
Price Target: $85 → $87
Current: $82.98
Upside: +4.84%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $5.27
Upside: +127.70%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $82.20
Upside: -8.76%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $19.82
Upside: +21.09%
Oct 13, 2023
Maintains: Buy
Price Target: $390 → $90
Current: $17.75
Upside: +407.04%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $12.57
Upside: +98.89%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $52.83
Upside: +112.00%